D. Nazareth

932 total citations
56 papers, 500 citations indexed

About

D. Nazareth is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Speech and Hearing. According to data from OpenAlex, D. Nazareth has authored 56 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 7 papers in Speech and Hearing. Recurrent topics in D. Nazareth's work include Cystic Fibrosis Research Advances (39 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers) and Pediatric health and respiratory diseases (5 papers). D. Nazareth is often cited by papers focused on Cystic Fibrosis Research Advances (39 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers) and Pediatric health and respiratory diseases (5 papers). D. Nazareth collaborates with scholars based in United Kingdom, India and United States. D. Nazareth's co-authors include Martin Walshaw, Freddy Frost, Craig Winstanley, Susan C. Charman, Matthew Shaw, Anura V. Kurpad, Vernon R. Young, Justin Gnanou, Meredith M. Regan and M. Al-Aloul and has published in prestigious journals such as PLoS ONE, American Journal of Clinical Nutrition and Radiology.

In The Last Decade

D. Nazareth

48 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Nazareth United Kingdom 13 337 63 59 47 42 56 500
F. Teding van Berkhout Netherlands 13 274 0.8× 87 1.4× 73 1.2× 38 0.8× 6 0.1× 23 497
Adyléia Aparecida Dalbo Contrera Toro Brazil 14 316 0.9× 86 1.4× 53 0.9× 297 6.3× 9 0.2× 53 633
Patrick Viet-Quoc Nguyen Canada 8 53 0.2× 56 0.9× 56 0.9× 72 1.5× 7 0.2× 22 462
Ewa Gulczyńska Poland 15 294 0.9× 157 2.5× 135 2.3× 30 0.6× 4 0.1× 71 679
R. K. Whyte Canada 12 96 0.3× 98 1.6× 40 0.7× 43 0.9× 15 0.4× 26 427
Malcolm Miller South Africa 9 86 0.3× 42 0.7× 155 2.6× 56 1.2× 11 0.3× 23 326
Shelley C. Springer United States 6 87 0.3× 104 1.7× 67 1.1× 43 0.9× 8 0.2× 10 524
Maryam Hassanzad Iran 12 179 0.5× 103 1.6× 35 0.6× 69 1.5× 12 0.3× 73 386
Ti Yin Taiwan 14 68 0.2× 49 0.8× 68 1.2× 13 0.3× 11 0.3× 27 509
Elena Martelli Italy 12 272 0.8× 72 1.1× 109 1.8× 14 0.3× 4 0.1× 21 723

Countries citing papers authored by D. Nazareth

Since Specialization
Citations

This map shows the geographic impact of D. Nazareth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Nazareth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Nazareth more than expected).

Fields of papers citing papers by D. Nazareth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Nazareth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Nazareth. The network helps show where D. Nazareth may publish in the future.

Co-authorship network of co-authors of D. Nazareth

This figure shows the co-authorship network connecting the top 25 collaborators of D. Nazareth. A scholar is included among the top collaborators of D. Nazareth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Nazareth. D. Nazareth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frost, Freddy, et al.. (2025). Multimorbidity in the modulator era: challenges of managing an ageing cystic fibrosis population. Expert Review of Respiratory Medicine. 20(3). 267–277.
2.
3.
Frost, Freddy, D. Nazareth, Laurent Fauchier, et al.. (2023). Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: a multinational retrospective cohort study. European Respiratory Journal. 62(4). 2300174–2300174. 18 indexed citations
4.
Nazareth, D., et al.. (2022). Use of Dynamic Chest Radiography to Assess Treatment of Pulmonary Exacerbations in Cystic Fibrosis. Radiology. 303(3). 675–681. 14 indexed citations
5.
Shelley, James, Ellen A. Dawson, Lynne M. Boddy, et al.. (2022). Developing an ecological approach to physical activity promotion in adults with Cystic fibrosis. PLoS ONE. 17(8). e0272355–e0272355. 3 indexed citations
6.
Nazareth, D., et al.. (2022). Measuring the effect of elexacaftor/tezacaftor/ivacaftor combination therapy on the respiratory pump in people with CF using dynamic chest radiography. Journal of Cystic Fibrosis. 21(6). 1036–1041. 10 indexed citations
7.
Frost, Freddy, Gregory R. Young, Laura Wright, et al.. (2021). The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover study (AZTEC-CF). Journal of Cystic Fibrosis. 20(6). 994–1002. 12 indexed citations
8.
Nazareth, D., et al.. (2021). Characterisation of hemidiaphragm dysfunction using dynamic chest radiography: a pilot study. ERJ Open Research. 8(1). 343–2021. 9 indexed citations
9.
McNamara, Paul, et al.. (2020). Utility and validity of dynamic chest radiography in cystic fibrosis (dynamic CF): an observational, non-controlled, non-randomised, single-centre, prospective study. BMJ Open Respiratory Research. 7(1). e000569–e000569. 5 indexed citations
10.
11.
Frost, Freddy, D. Nazareth, Susan C. Charman, Craig Winstanley, & Martin Walshaw. (2019). Ivacaftor Is Associated with Reduced Lung Infection by Key Cystic Fibrosis Pathogens. A Cohort Study Using National Registry Data. Annals of the American Thoracic Society. 16(11). 1375–1382. 72 indexed citations
12.
Frost, Freddy, et al.. (2019). <p>Cystic fibrosis-related diabetes: optimizing care with a multidisciplinary approach</p>. Diabetes Metabolic Syndrome and Obesity. Volume 12. 545–552. 12 indexed citations
13.
Taylor‐Cousar, Jennifer L., Nico Derichs, D. Elizabeth Tullis, et al.. (2017). Safety, Tolerability and early signs of efficacy with riociguat for the treatment of adult PHE508DEL homozygous cystic fibrosis patients: safety data from the RIO-CF study. Pediatric Pulmonology. 52. 1 indexed citations
14.
Al-Aloul, M., D. Nazareth, & Martin Walshaw. (2013). Nebulized Tobramycin in the Treatment of Adult CF Pulmonary Exacerbations. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 27(4). 299–305. 14 indexed citations
15.
Nazareth, D. & Martin Walshaw. (2013). A review of renal disease in cystic fibrosis. Journal of Cystic Fibrosis. 12(4). 309–317. 54 indexed citations
16.
Nazareth, D. & Martin Walshaw. (2013). Coming of age in cystic fibrosis – transition from paediatric to adult care. Clinical Medicine. 13(5). 482–486. 18 indexed citations
17.
Nazareth, D., et al.. (2012). Fracture and Intra-Cardiac Embolisation of a Totally Implantable Vascular Access Device. Respiration. 83(6). 553–553. 1 indexed citations
18.
Pfeffer, Paul, et al.. (2011). Are weekend handovers of adequate quality for the on-call general medical team?. Clinical Medicine. 11(6). 536–540. 12 indexed citations
19.
Kurpad, Anura V., et al.. (2003). Intestinal parasites increase the dietary lysine requirement in chronically undernourished Indian men. American Journal of Clinical Nutrition. 78(6). 1145–1151. 37 indexed citations
20.
Kurpad, Anura V., Tony Raj, Meredith M. Regan, et al.. (2002). Threonine requirements of healthy Indian men, measured by a 24-h indicator amino acid oxidation and balance technique. American Journal of Clinical Nutrition. 76(4). 789–797. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Teding van Berkhout Breakdown of academic impact, for papers by Adyléia Aparecida Dalbo Contrera Toro Breakdown of academic impact, for papers by Patrick Viet-Quoc Nguyen Breakdown of academic impact, for papers by Ewa Gulczyńska Breakdown of academic impact, for papers by R. K. Whyte Breakdown of academic impact, for papers by Malcolm Miller Breakdown of academic impact, for papers by Shelley C. Springer Breakdown of academic impact, for papers by Maryam Hassanzad Breakdown of academic impact, for papers by Ti Yin Breakdown of academic impact, for papers by Elena Martelli
Rankless by CCL
2026